Cambridge Investment Research Advisors’s Goldman Sachs Enhanced U.S. Equity ETF GUSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
5,695
-66
-1% -$2.86K ﹤0.01% 3588
2026
Q1
$225K Buy
5,761
+557
+11% +$22.6K ﹤0.01% 3577
2025
Q4
$211K Buy
+5,204
New +$210K ﹤0.01% 3533

Other funds holding GUSE

Cambridge Investment Research Advisors's GUSE Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Goldman Sachs Enhanced U.S. Equity ETF (GUSE) stake by 1.1% in Q2 2026, selling an estimated $2.86K and leaving 5,695 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #3588.

Cambridge Investment Research Advisors first reported a position in GUSE in Q4 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold GUSE as of Q2 2026.

  • Cambridge Investment Research Advisors held 5,695 shares of Goldman Sachs Enhanced U.S. Equity ETF worth $257K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 66 Goldman Sachs Enhanced U.S. Equity ETF shares in Q2 2026, an estimated $2.86K.
  • Goldman Sachs Enhanced U.S. Equity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3588 holding.
  • Cambridge Investment Research Advisors first reported a position in Goldman Sachs Enhanced U.S. Equity ETF in Q4 2025 and has held it in 3 quarters since.
  • 6 funds tracked by Wall St. Rank held Goldman Sachs Enhanced U.S. Equity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.